Review tracks scent-based prostate cancer diagnostics from dogs to AI

Version 1

A new review in Life maps the fast-growing field of scent-based prostate cancer diagnostics, tracing the science from animal olfaction models to artificial intelligence-enabled “electronic nose” systems. The paper argues that volatile organic compounds, or VOCs, in urine and other biosamples could support a more accurate, non-invasive approach to prostate cancer detection, while also underscoring that the field is still limited by small studies, inconsistent methods, and a lack of standardized biomarkers. Related research cited in the broader literature shows why interest remains high: a 2024 systematic review found promising evidence for urinary VOC analysis in prostate cancer, and prior Johns Hopkins-led work combined trained dogs, GC-MS, and AI to explore whether canine scent detection could be translated into scalable machine olfaction. (pubmed.ncbi.nlm.nih.gov)

Why it matters: For veterinary professionals, this is another example of animal olfaction informing human diagnostics, with dogs continuing to serve as both proof of concept and translational models for disease detection by scent. That matters not only for comparative oncology, but also for working-dog medicine, training standards, and the broader veterinary role in One Health research. At the same time, the evidence base remains early: a meta-analysis reported strong pooled diagnostic performance for canine urine detection of prostate cancer, but experts continue to flag the need for larger, prospective, standardized validation before these tools can move into routine clinical use. (pmc.ncbi.nlm.nih.gov)

What to watch: Watch for larger multicenter validation studies, efforts to standardize urine VOC collection and analysis, and continued attempts to turn canine-inspired scent signatures into regulated AI or sensor-based diagnostics. (hopkinsmedicine.org)